Study at a glance
What do CYP27B1 and CYP24A1 do?
They are enzymes, proteins that carry out chemical reactions. CYP27B1 helps make calcitriol, the active vitamin D hormone. CYP24A1 helps break down active vitamin D and the earlier form in the blood that is used to make it.
Why do these vitamin D enzymes behave differently across tissues?
Cells receive different signals and control the same genes differently. The kidneys help regulate the hormone circulating around the body; other cells may mainly control their own local supply.
Does finding a vitamin D enzyme prove that a tissue makes a lot of active hormone?
No. The enzyme needs starting material and suitable conditions. Its presence alone does not show how much hormone is made or whether it reaches the bloodstream.
What can the mouse experiments tell us about people?
They show how changing regions that control genes can alter kidney responses. They support a biological principle, but their exact effects cannot simply be assumed to occur in human tissues.
Read the full article below ↓CYP27B1 and CYP24A1 perform recognisable biochemical reactions wherever the enzymes are expressed, but the physiological meaning of those reactions changes with tissue context. In kidney, the pair helps regulate the circulating calcitriol supply and therefore systemic calcium and phosphate homeostasis. In many non-renal tissues, the same enzymes are used more locally, shaping the vitamin D signal experienced within a cell or tissue. The difference is not simply where the genes are present; it is how substrate delivery, chromatin, hormone receptors and local signalling determine what the enzymes actually do.
The kidney uses CYP27B1 and CYP24A1 as an endocrine control pair
Renal proximal tubular cells occupy a special position in vitamin D physiology. The Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1) overview explains the core reactions that this renal control system coordinates. They receive filtered 25(OH)D through specialised uptake mechanisms and contain the machinery needed to convert that precursor to calcitriol. Because the kidney is the principal regulated source of circulating calcitriol, changing renal CYP27B1 can alter hormone supply throughout the body.
CYP24A1 provides the counterweight. It metabolises 25(OH)D and calcitriol, helping limit both precursor availability and active-hormone persistence. PTH, FGF23 and calcitriol regulate the two enzymes in reciprocal directions, allowing the kidney to adjust production and removal as mineral conditions change.
This reciprocal endocrine role is why a renal change can have systemic consequences even when the same enzymes are also present elsewhere.
Non-renal tissues can use the same enzymes for local control
Extra-renal CYP27B1 is found in a range of tissues and cell types. Tissue-Specific Vitamin D Metabolism develops how those reactions are reshaped across individual tissues. Its presence allows local conversion of 25(OH)D to calcitriol, supporting intracrine or paracrine signalling. CYP24A1 can then limit that local exposure by metabolising precursor or active hormone.
The crucial point is scale. Local synthesis does not automatically mean that a tissue contributes substantially to circulating calcitriol. A cell may create enough hormone to alter its own transcriptional programme while adding very little to the endocrine pool measured in blood.
This distinction helps reconcile two observations that can otherwise seem contradictory: CYP27B1 is widely expressed, yet kidney remains the dominant regulated endocrine source under ordinary conditions.
Chromatin architecture helps explain why the same gene responds differently
Meyer and colleagues provided a direct genomic example with Cyp24a1. In mouse kidney, a downstream region rich in pCREB binding was required for normal basal renal expression and for major PTH and FGF23 responses. VDR-responsive control was distributed more broadly across the locus and remained partly functional when individual downstream VDR-rich regions were deleted.
The pattern was different in non-renal target cells. Strong kidney-selective pCREB occupancy was not reproduced uniformly, while VDR-dependent regulation was more broadly shared. This means the same Cyp24a1 coding sequence can sit inside different regulatory environments and therefore respond to different combinations of hormones and transcription factors.
Tissue-specific vitamin D metabolism is therefore partly a problem of gene regulation, not simply enzyme chemistry.
Local regulation is heterogeneous, not one universal extra-renal programme
“Extra-renal” is a location category, not a single physiological system. Intestine, immune cells, skin-associated cells, bone-related cells and other tissues differ in substrate access, receptor expression, inflammatory signals and chromatin state.
That is why renal rules should not be copied wholesale onto every other tissue. A PTH or FGF23 response that is central to kidney may be weak, absent or context dependent elsewhere, while local calcitriol/VDR feedback can remain strong.
The same caution applies in the other direction. Finding that one non-renal model lacks a particular response does not prove that every tissue outside kidney behaves identically.
Disease shows how a local pathway can become systemic
Granulomatous disease provides a useful boundary case. Activated macrophages can express substantial CYP27B1 activity. In disorders such as sarcoidosis or tuberculosis, extra-renal calcitriol production can become high enough to contribute to systemic hypercalcaemia.
The pathological state does not erase the normal distinction between local and endocrine production. Instead, it demonstrates what happens when a normally local capacity becomes dysregulated and large enough to affect the circulation.
That same principle helps avoid overinterpreting ordinary tissue expression: the existence of local CYP27B1 is not evidence that normal extra-renal tissues collectively replace kidney endocrine control.
Catabolism also varies by tissue and metabolic setting
CYP24A1 is the specialised vitamin D catabolic enzyme integrated into VDR feedback, but it is not the only oxidative route available in every tissue. CYP3A4 can also metabolise vitamin D compounds, particularly in liver and intestine and in settings where CYP3A4 activity is high or induced.
This adds another layer of tissue dependence. Two tissues can differ not only in CYP27B1 and CYP24A1 regulation but in the relative importance of alternative metabolic pathways. Local vitamin D exposure is therefore the result of several interacting variables rather than a universal two-enzyme formula.
Human and mouse regulatory maps are related but not identical
Mouse genetic deletion experiments provide powerful causal evidence because specific regulatory regions can be removed and the resulting hormone responses measured. Human kidney chromatin shows broadly related VDR, pCREB and enhancer-associated territories around CYP24A1, supporting conservation of the regulatory principle.
The geometry is not identical, however. Human regulatory regions are more overlapping and complex than the simple mouse DS1/DS2 distinction suggests. Mouse causal effect sizes therefore should not be projected directly onto human tissues.
The strongest cross-species conclusion is that tissue-specific regulatory architecture is real and relevant, while the exact arrangement and quantitative contribution of individual enhancers can differ.
How to interpret CYP27B1 and CYP24A1 across tissues
When evaluating either enzyme in a tissue, four separate questions matter: Is the enzyme expressed? Is substrate available? Which hormonal or local signals regulate the gene? And is the resulting metabolite production large enough to matter locally, systemically, or both? Expression alone answers only the first question.
An observed change in CYP27B1 or CYP24A1 therefore has to be interpreted alongside substrate delivery, the active signalling environment, the size of the local metabolite pool and the tissue’s connection to the circulation. The same numerical change can have very different consequences in a renal endocrine compartment and in a small peripheral cell population. One can alter systemic calcitriol supply; the other may mainly change local VDR exposure.
Enzyme chemistry defines what can happen; tissue context determines the scale, regulation and biological consequence.
Related reading
The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice
We found that 1,25-dihydroxyvitamin D levels in plasma were significantly lower in the high phosphate group than the low phosphate group for 1 and 2 month-old mice, but not 13 month-old mice.
Original paper ↗Read more →Loss of 24-hydroxylated catabolism increases calcitriol and fibroblast growth factor 23 and alters calcium and phosphate metabolism in fetal mice
The null fetuses were hypercalcemic, modestly hypophosphatemic (compared to Cyp24a1+/− fetuses only), with 3.5-fold increased calcitriol, 4-fold increased fibroblast growth factor 23 (FGF23), and unchanged parathyroid hormone.
Original paper ↗Read more →Klotho in the kidney distal convolution regulates urinary Klotho excretion and kidney calcium reabsorption, but not phosphate homeostasis
Klotho acts as a coreceptor for the phosphaturic hormone fibroblast growth factor-23 (FGF-23) and exists in both a membrane-bound and a soluble form (sKlotho) found in blood and urine.
Original paper ↗Read more →Association of increased renal Cyp24a1 gene expression with low plasma 1,25-dihydroxyvitamin D levels in rats with streptozotocin-induced diabetes
Here, we investigated the association between Cyp24a1, a vitamin D catabolic enzyme, and abnormalities in vitamin D metabolism in streptozotocin-induced diabetes rats, an animal model of type 1 diabetes.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Tissue-Wide Expression of Genes Related to Vitamin D Metabolism and FGF23 Signaling following Variable Phosphorus Intake in Pigs
Calcium (Ca) and phosphorus (P) homeostasis is maintained by several regulators, including vitamin D and fibroblast growth factor 23 (FGF23), and their tissue-specific activation and signaling cascades.
Original paper ↗Read more →From Vitamin D Activation to Clearance: The CYP27B1: CYP24A1 Balance
Explore how CYP27B1-mediated vitamin D activation and CYP24A1-mediated metabolism work together to regulate calcitriol availability, signalling and clearance.SLUG:cyp27b1-cyp24a1-activation-clearance-bridge.
Read more →Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1)
Vitamin D enzyme pathways regulate how vitamin D is activated and broken down in the body.
Read more →Combined Treatment with Omega-3 Fatty Acid and Cholecalciferol Increases 1,25-Dihydroxyvitamin D Levels by Modulating Dysregulation of Vitamin D Metabolism in 5/6 Nephrectomy Rats
The aim of this study was to determine whether omega-3 FA and cholecalciferol have effects on vitamin D metabolism related to CYP27B1 and 24-hydroxylase (CYP24) activities in the kidney and liver of 5/6 nephrectomy (Nx) rats.
Original paper ↗Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Dietary phosphorus source reprograms the kidney-intestine axis to dictate calcium-phosphorus efficiency and egg production in aging hens
The decline in egg production in aging hens poses a significant challenge to sustainable poultry production.
Original paper ↗Read more →Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function
Plasma approaches metastability with respect to its calcium and phosphate content, with only minor perturbations in ionic activity needed to sustain crystal growth once nucleated.
Original paper ↗Read more →Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial
This secondary analysis of the DASH trial aimed to determine the effect of dietary patterns on blood concentrations of calcitriol, parathyroid hormone (PTH), ionized calcium, and urinary excretion of calcium and phosphorus.
Original paper ↗Read more →Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults without confounding cardiovascular disease.
Original paper ↗Read more →High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss
Phosphate overload contributes to mineral bone disorders that are associated with crystal nephropathies.
Original paper ↗Read more →Impact of microgravity on a three-dimensional microphysiologic culture of the human kidney proximal tubule epithelium: cell response to serum and vitamin D
We used this unique environment to evaluate the effects of microgravity on kidney proximal tubule epithelial cell (PTEC) response to serum exposure and vitamin D biotransformation capacity.
Original paper ↗Read more →Modeling cellular responses to serum and vitamin D in microgravity using a human kidney microphysiological system
We used this unique environment to evaluate the effects of microgravity on kidney proximal tubule epithelial cell (PTEC) response to serum exposure and vitamin D biotransformation capacity.
Original paper ↗Read more →Phosphate, calcium, and vitamin D signaling, transport, and metabolism in the endometria of cyclic ewes
However, the effects of P4 and estradiol (E2), with respect to the expression of their receptors PGR and ESR1, respectively, in uterine epithelia on mineral signaling during the estrous cycle has not been investigated.
Original paper ↗Read more →Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)
This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants.
Original paper ↗Read more →Reduced phosphorus intake throughout gestation and lactation of sows is mitigated by transcriptional adaptations in kidney and intestine
L diets led to an increase in CYP27B1 expression in the kidney compared to the H group and to an altered gene expression associated with lipid metabolism in the kidney and immune response in the jejunum.
Original paper ↗Read more →The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis: clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD.
Original paper ↗Read more →